Years after pinpointing a faulty protein in the brains of patients diagnosed with Parkinson’s disease, researchers have made another breakthrough.The team at the University of Sydney was able to target this SOD1 protein with a drug treatment in mice. They observed a “dramatic” improvement in their motor skills.Now comes the tricky task of figuring out how to target the SOD1 protein safely in humans, paving the way for a potential treatment to slow progression.Guest/sProfessor Kay Double, Brain and Mind Centre at the University of SydneyReferencesCopper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related